SMARCC1 and breast cancer: In details, ginsenoside Rg3 can affect cell proliferation through a variety of pathways, including inducing protein synthesis, cell division, and inhibiting nuclear factor kappa-B (NF-κB) signaling (Zou et al., 2018), among which, SRg3 inhibits BC cells proliferation by arresting the cell cycle of G0/G1 (Nakhjavani et al., 2019).